Flagship Wealth Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.04K Buy
+300
New +$8.05K ﹤0.01% 403

Other funds holding ACAD

Flagship Wealth Advisors's ACAD Position: Q3 2026 in Review

Flagship Wealth Advisors opened a new position in Acadia Pharmaceuticals (ACAD) in Q3 2026: 300 shares worth $6.04K. The stake represents ﹤0.01% of the portfolio and ranks #403 among its holdings.

350 funds tracked by Wall St. Rank hold ACAD as of Q3 2026.

  • Flagship Wealth Advisors held 300 shares of Acadia Pharmaceuticals worth $6.04K as of Q3 2026.
  • Acadia Pharmaceuticals was a new Flagship Wealth Advisors position in Q3 2026.
  • Acadia Pharmaceuticals made up ﹤0.01% of Flagship Wealth Advisors's portfolio in Q3 2026, its #403 holding.
  • 350 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2026.

Based on Flagship Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.